AR026913A1 - Analogos de (1s-cis)-4-(2-amino-9h-purin-9-il)-2-ciclopenten-1-metanol para uso en el tratamiento de infecciones virales - Google Patents

Analogos de (1s-cis)-4-(2-amino-9h-purin-9-il)-2-ciclopenten-1-metanol para uso en el tratamiento de infecciones virales

Info

Publication number
AR026913A1
AR026913A1 ARP000106509A ARP000106509A AR026913A1 AR 026913 A1 AR026913 A1 AR 026913A1 AR P000106509 A ARP000106509 A AR P000106509A AR P000106509 A ARP000106509 A AR P000106509A AR 026913 A1 AR026913 A1 AR 026913A1
Authority
AR
Argentina
Prior art keywords
purin
analogs
cis
methanol
amino
Prior art date
Application number
ARP000106509A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AR026913A1 publication Critical patent/AR026913A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Abstract

La presente invencion se refiere a análogos de (1S,cis)-4-(2-amino-9H-purin-9-il)-2-ciclopenteno-1-metanol para usarse en el tratamiento de infeccionesvirales.
ARP000106509A 1999-12-10 2000-12-07 Analogos de (1s-cis)-4-(2-amino-9h-purin-9-il)-2-ciclopenten-1-metanol para uso en el tratamiento de infecciones virales AR026913A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17022599P 1999-12-10 1999-12-10

Publications (1)

Publication Number Publication Date
AR026913A1 true AR026913A1 (es) 2003-03-05

Family

ID=22619059

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000106509A AR026913A1 (es) 1999-12-10 2000-12-07 Analogos de (1s-cis)-4-(2-amino-9h-purin-9-il)-2-ciclopenten-1-metanol para uso en el tratamiento de infecciones virales

Country Status (9)

Country Link
EP (1) EP1235833B1 (es)
JP (1) JP2003516409A (es)
AR (1) AR026913A1 (es)
AT (1) ATE260288T1 (es)
AU (1) AU2068901A (es)
DE (1) DE60008580T2 (es)
ES (1) ES2213061T3 (es)
PE (1) PE20010915A1 (es)
WO (1) WO2001042256A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201513601D0 (en) * 2015-07-31 2015-09-16 Univ Liverpool Antiviral compounds
TW202019942A (zh) 2018-07-27 2020-06-01 日商富士軟片股份有限公司 環戊烯嘌呤衍生物或其鹽

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
GB9505025D0 (en) * 1995-03-13 1995-05-03 Medical Res Council Chemical compounds
GB9821058D0 (en) * 1998-09-28 1998-11-18 Univ Cardiff Chemical compound
DK1150988T3 (da) * 1999-02-12 2003-09-29 Glaxo Group Ltd Phosphoramidat og mono-, di- og triphosphorsyreestere af (1R,cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopenten-1-methanol som antivirale midler

Also Published As

Publication number Publication date
DE60008580D1 (en) 2004-04-01
ES2213061T3 (es) 2004-08-16
JP2003516409A (ja) 2003-05-13
AU2068901A (en) 2001-06-18
WO2001042256A1 (en) 2001-06-14
PE20010915A1 (es) 2001-09-29
DE60008580T2 (de) 2004-08-05
ATE260288T1 (de) 2004-03-15
EP1235833B1 (en) 2004-02-25
EP1235833A1 (en) 2002-09-04

Similar Documents

Publication Publication Date Title
ECSP045069A (es) Uso de flibanserina en el tratamiento de trastornos sexuales
HN2001000190A (es) Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento
HN1999000015A (es) Tratamiento para una disfuncion sexual femenina
MXPA03006093A (es) Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
PT1265889E (pt) Medicamentos contra patologias virais
ES2156603T3 (es) Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.
BR0311693A (pt) Sal de formato de o-desmetil-venlafaxina
AR031975A1 (es) Compuestos analogos de (1r,cis)-4-(6-amino-9h-purin-9-il) -2-ciclopenteno-1-metanol, proceso para su preparacion, su uso en el tratamiento de infecciones virales, y envase que los contiene
UY26495A1 (es) " derivados de tiazolilamida"
TW200505875A (en) Novel compounds
ATE303149T1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
MY129372A (en) Process to prepare oxazolidinones
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
SE9901077D0 (sv) Novel use
DK1729732T3 (da) Anioniske hydrogelmatricer med pH-afhængig frigivelse som lægemiddelbærere
HN1998000099A (es) Formas de dosificacion de sertralina de liberacion retardada
CR9108A (es) Prevencion de infecciones endoparasitas verticales
AR026913A1 (es) Analogos de (1s-cis)-4-(2-amino-9h-purin-9-il)-2-ciclopenten-1-metanol para uso en el tratamiento de infecciones virales
PL376130A1 (en) Controlled releases system containing temozolomide
PE20011080A1 (es) Uso de mirtazapina para el tratamiento de trastornos del sueno
PT1357932E (pt) Modificacao cristalina de um depsipeptido ciclico com eficacia melhorada
BRPI0409175A (pt) preparação farmacêutica oral para antagonistas de bombeamento de próton
BR0006843A (pt) Dispositivo de embreagem
TW200613271A (en) Crystalline forms of 1,24(s)-dihydroxy vitamin d2
DK1401492T3 (da) LTB4 som vaccineadjuvans

Legal Events

Date Code Title Description
FB Suspension of granting procedure